Biomarker-driven treatment for muscle-invasive bladder cancer (MIBC) led to a 2-year metastasis-free survival (MFS) rate that ...

The research team designed a new diagnostic kit that detects bladder cancer biomarkers by utilizing the principle of layering ...

While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...

biomarkers, and genomic analyses holds promise. We eagerly await the results of clinical trials investigating these tools, which may allow for the safe recommendation of bladder-sparing therapy.

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

Learn about the promising Monopar Therapeutics Inc. MNPR-101 treatment targeting solid tumors and how it aims to reduce ...

The prevalence of cancer is escalating at an alarming rate globally, underscoring the need for robust diagnostic solutions. Factors such as growing awareness, supportive government initiatives, and ...

Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma; HCC), gall bladder, and bile ducts (collectively called biliary tract cancers). The most ...

The firm plans to launch trials to study the agent in biomarker-defined cancer types, including breast and lung cancers.